Literature DB >> 4086658

An autoradiographic study of projections ascending from the midbrain central gray, and from the region lateral to it, in the rat.

J A Eberhart, J I Morrell, M S Krieger, D W Pfaff.   

Abstract

Ascending projections from the midbrain central gray (CG) and from the region lateral to it were traced in the rat using tritiated amino acid autoradiography. Leucine or a cocktail of amino acids (leucine, proline, lysine, histidine, and tyrosine) were used as tracers. In addition to projections within the midbrain, ascending fibers follow three trajectories. The ventral projection passes through the ventral tegmental region of Tsai and the medial forebrain bundle to reach the hypothalamus, preoptic area, caudoputamen, substantia innominata, stria terminalis, and amygdala. There are labeled fibers in the diagonal bands of Broca and medial septum, and terminal labeling in the lateral septum, nucleus accumbens, olfactory tubercle, and frontal cortex. The dorsal periventricular projection terminates in the midline and intralaminar thalamic nuclei. The ventral periventricular projection follows the ventral component of the third ventricle into the hypothalamus, passing primarily through the dorsal hypothalamic area and labeling the rostral hypothalamus and preoptic area. Projections from the region lateral to the CG are similar, but exhibit stronger proximal, and weaker distal, projections. Rostral levels of the CG send heavier projections to the fields of Forel and the zona incerta, but fewer fibers through the supraoptic decussation, than do caudal levels. Ascending projections from the CG are both strong and widespread. Strong projections to the limbic system and the intralaminar thalamic nuclei provide an anatomical substrate for CG involvement in nociception and affective responses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4086658     DOI: 10.1002/cne.902410305

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  9 in total

1.  GABAA receptor signaling in caudal periaqueductal gray regulates maternal aggression and maternal care in mice.

Authors:  Grace Lee; Stephen C Gammie
Journal:  Behav Brain Res       Date:  2010-05-08       Impact factor: 3.332

2.  Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter.

Authors:  Jun Lu; Thomas C Jhou; Clifford B Saper
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

3.  Demonstration of a reciprocal connection between the periaqueductal gray matter and the reticular nucleus of the thalamus.

Authors:  E Rinvik; M Wiberg
Journal:  Anat Embryol (Berl)       Date:  1990

4.  Hypothalamic regulation of headache and migraine.

Authors:  Arne May; Rami Burstein
Journal:  Cephalalgia       Date:  2019-08-29       Impact factor: 6.292

5.  Vestibulospinal and reticulospinal interactions in the activation of back muscle EMG in the rat.

Authors:  S L Cottingham; P A Femano; D W Pfaff
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

Review 6.  Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory.

Authors:  Satoshi Ikemoto
Journal:  Neurosci Biobehav Rev       Date:  2010-02-10       Impact factor: 8.989

7.  A cholecystokinin-mediated pathway to the paraventricular thalamus is recruited in chronically stressed rats and regulates hypothalamic-pituitary-adrenal function.

Authors:  S Bhatnagar; V Viau; A Chu; L Soriano; O C Meijer; M F Dallman
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

8.  Periaqueductal gray afferents synapse onto dopamine and GABA neurons in the rat ventral tegmental area.

Authors:  Natalia Omelchenko; Susan R Sesack
Journal:  J Neurosci Res       Date:  2010-04       Impact factor: 4.164

9.  Anterior pretectal stimulation alters the responses of spinal dorsal horn neurones to cutaneous stimulation in the rat.

Authors:  H Rees; M H Roberts
Journal:  J Physiol       Date:  1987-04       Impact factor: 5.182

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.